ADHD Drugs To Have Warnings On Contra Indications

by Jyothsna on  February 22, 2007 at 4:00 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

ADHD Drugs To Have Warnings On Contra Indications
The Food and Drug Administration ordered the makers of ADHD drugs to indicate the contra indications clearly to the patients, the significant ones being psychiatric and cardiovascular risks.

Dr. Steven Galson, director of the FDA's Center for Drug Evaluation and Research said that although these drugs are immensely useful in treating patients with ADHD, the risks also should be made known to the public. He also said that FDA is working in tandem with drug manufacturers in giving information to doctors and patients on the drugs.

Some of the risks in using ADHD drugs as reported in a FDA bulletin are related to stroke, heart attacks and cardio vascular ailments. Adverse effect on the psychiatric front is also reported in a few cases.

FDA's Pediatric Advisory Committee and the Drug Safety and Risk Management Advisory Committee urged the drug companies to alter their warnings on labels in May 2006. They are also working to bring out Patient Medication Guides.

Source: Medindia
JYT

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Dyslexia Attention Deficit Hyperactivity Disorder (ADHD) Signature Drug Toxicity Bullying at School - Tips For Schools ADHD Dyscalculia / Learning Disabilities Drugs Banned in India Diet to control Attention Deficit Hyperactivity Disorder 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...